SCHEMBL5879506

SCHEMBL5879506

NCc1ccc(-c2nc3ccccc3[nH]2)s1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 14/20 0.63
▸ RAB9A P51151 14/20 0.63
▸ SMN1; SMN2 Q16637 13/20 0.63
▸ ALDH1A1 P00352 13/20 0.63
▸ KDM4E B2RXH2 10/20 0.63
▸ HPGD P15428 10/20 0.63
▸ HSD17B10 Q99714 8/20 0.63
▸ TP53 P04637 7/20 0.63
▸ NFKB1 P19838 1/20 0.63
▸ NFKB2 Q00653 1/20 0.63
▸ RELA Q04206 1/20 0.63
▸ NPSR1 Q6W5P4 4/20 0.53
▸ PKM P14618 4/20 0.53
▸ ABCB11 O95342 1/20 0.53
▸ GAA P10253 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ CYP2E1 P05181 1/20 0.47
▸ CYP2A6 P11509 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12543424 0.84 NPC1 (0.80) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL3336113 0.78 NPC1 (1.00) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL23566014 0.76 KDM4E (0.69) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL5879594 0.74 SMN1; SMN2 (0.54) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL30634854 0.72 NPC1 (1.00) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL30561047 0.72 NPC1 (1.00) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL172216 0.72 NPC1 (1.00) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL12713528 0.71 RAB9A (0.60) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
Water SCHEMBL9817804 0.70 NPC1 (0.95) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL5023990 0.70 NPC1 (0.68) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105508-B1 Integrin receptors antagonists ABBOTT GMBH & CO. KG (DE) 2006-09-12 — — US disclosed
EP-1202988-A2 NOVEL INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2002-05-08 — — EP disclosed
WO-2001010847-A2 NOVEL INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2001-02-15 — — WO disclosed
Send feedback